Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
Sun Woong Kim, Jun Sik Yoon, Minjong Lee, Yuri Cho
Clin Mol Hepatol. 2022;28(1):17-30. Published online 2021 Jul 20 DOI: https://doi.org/10.3350/cmh.2021.0093
|
Citations to this article as recorded by
Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies
Hui Ma, Qing-Zhu Yan, Jing-Ru Ma, Dong-Fu Li, Jun-Ling Yang
World Journal of Gastroenterology.2024; 30(10): 1295. CrossRef Hepatitis B virus genotypes in precision medicine of hepatitis B-related hepatocellular carcinoma: Where we are now
Caecilia H C Sukowati, Sri Jayanti, Turyadi Turyadi, David H Muljono, Claudio Tiribelli
World Journal of Gastrointestinal Oncology.2024; 16(4): 1097. CrossRef N-Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H
Dimitrios Moianos, Maria Makri, Georgia-Myrto Prifti, Aristeidis Chiotellis, Alexandros Pappas, Molly E. Woodson, Razia Tajwar, John E. Tavis, Grigoris Zoidis
Molecules.2024; 29(12): 2942. CrossRef SOD1 inhibition enhances sorafenib efficacy in HBV‐related hepatocellular carcinoma by modulating PI3K/Akt/mTOR pathway and ROS‐mediated cell death
Jooyoung Lee, Jiye Kim, Ryunjin Lee, Eunkyeong Lee, Hye‐In An, Yong‐Jae Kwon, Hana Jin, Chan‐Gi Pack, Inki Kim, Young‐In Yoon, Gil‐Chun Park, Eun‐Kyoung Jwa, Jae Hyun Kwon, Jung‐Man Namgoong, Gi‐Won Song, Shin Hwang, Eunyoung Tak, Sung‐Gyu Lee
Journal of Cellular and Molecular Medicine.2024;[Epub] CrossRef Rupestonic Acid Derivative YZH-106 Promotes Lysosomal Degradation of HBV L- and M-HBsAg via Direct Interaction with PreS2 Domain
Lanlan Liu, Haoyu Wang, Lulu Liu, Fang Cheng, Haji Akber Aisa, Changfei Li, Songdong Meng
Viruses.2024; 16(7): 1151. CrossRef Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction
Mehrangiz Dezhbord, Seong Ho Kim, Soree Park, Da Rae Lee, Nayeon Kim, Juhee Won, Ah Ram Lee, Dong-Sik Kim, Kyun-Hwan Kim
Clinical and Molecular Hepatology.2024; 30(3): 539. CrossRef Diagnostic Utility of Pre-Genomic Hepatitis B RNA in the Evaluation of HBV/HIV Coinfection
Kenneth Sherman, Susan Rouster, Heidi Meeds, Marion Peters, Jason Blackard, Paul Horn, Timothy Archampong, Awewura Kwara, Mark Anderson, Michael Stec, Gavin Cloherty
Pathogens and Immunity.2024; 9(2): 43. CrossRef Functional cure of chronic hepatitis B-hope or hype?
Gautam Ray
World Journal of Hepatology.2024; 16(9): 1199. CrossRef Antiviral Therapy for Chronic Hepatitis B Infection Improves Outcomes After Total Hip Arthroplasty: A Multicenter Retrospective Study
Tao Cheng, Guoyong Li, Huiming Ning, Liang Hao
The Journal of Arthroplasty.2023; 38(2): 300. CrossRef The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clinical and Molecular Hepatology.2023; 29(1): 99. CrossRef Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”
Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
Clinical and Molecular Hepatology.2023; 29(1): 191. CrossRef Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
Lilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
Clinical and Molecular Hepatology.2023; 29(1): 113. CrossRef Overview of the development of HBV small molecule inhibitors
Huihui Yang, Weiwei Yao, Jinfei Yang
European Journal of Medicinal Chemistry.2023; 249: 115128. CrossRef The progress of molecules and strategies for the treatment of HBV infection
Youlu Pan, Heye Xia, Yanwen He, Shenxin Zeng, Zhengrong Shen, Wenhai Huang
Frontiers in Cellular and Infection Microbiology.2023;[Epub] CrossRef Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice
Daisuke Ito, Hiroyasu Ito, Tatsuya Ando, Yasuhiro Sakai, Takayasu Ideta, Ken J. Ishii, Tetsuya Ishikawa, Masahito Shimizu
Hepatology Communications.2023;[Epub] CrossRef The role of different viral biomarkers on the management of chronic hepatitis B
Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen
Clinical and Molecular Hepatology.2023; 29(2): 263. CrossRef The latest global burden of liver cancer: A past and present threat
Joo Hyun Oh, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(2): 355. CrossRef Interactions of Na+/taurocholate cotransporting polypeptide with host cellular proteins upon hepatitis B and D virus infection: novel potential targets for antiviral therapy
Dariusz Zakrzewicz, Joachim Geyer
Biological Chemistry.2023; 404(7): 673. CrossRef Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
Alimentary Pharmacology & Therapeutics.2023; 58(1): 99. CrossRef Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
Heejin Cho, Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
BMC Gastroenterology.2023;[Epub] CrossRef Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
Beom Kyung Kim, Sang Hoon Ahn
Journal of the Formosan Medical Association.2023; 122(12): 1238. CrossRef Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Osamu Yoshida, Julio Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa
Biomedicines.2023; 11(7): 1944. CrossRef Chronic Hepatitis B Infection: Current and Emerging Therapeutic
Strategies
Ankita Singh, Jitendra Kumar, Vijay Kumar
Current Topics in Medicinal Chemistry.2023; 23(18): 1727. CrossRef Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA
An-Qi Zhuang, Yan Chen, Shan-Mei Chen, Wen-Cheng Liu, Yao Li, Wen-Jie Zhang, Yi-Hang Wu
Viruses.2023; 15(12): 2315. CrossRef Multitasking Na+/Taurocholate Cotransporting Polypeptide (NTCP) as a Drug Target for HBV Infection: From Protein Engineering to Drug Discovery
Dariusz Zakrzewicz, Joachim Geyer
Biomedicines.2022; 10(1): 196. CrossRef Genotypes Variation and Molecular Epidemiology Of The Hbv Chronic Liver Infection In The Local Population Of Pakistan: An Overview Of The Recent Literature
Bushra Tahreem, Ghadir Ali, Haroon Ahmad, Asim Shahzad, Muhammad Khurram, Nabiha Naeem, Aquib Nazar, Muhammad Haris, Hassan ., Shahrukh .
Pakistan BioMedical Journal.2022;[Epub] CrossRef KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2022; 28(2): 276. CrossRef Current Status of Drug Therapy for Chronic Hepatitis B
显明 尹
Advances in Clinical Medicine.2022; 12(07): 6196. CrossRef Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B
Chan‐Young Jung, Hyung Woo Kim, Jung Il Lee, Hyun Woong Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Liver International.2022; 42(11): 2408. CrossRef Design, Synthesis and Evaluation of Novel 4‐(4‐Chlorobenzyl)‐6‐methylpyridazin‐3(2H)‐one Derivatives as Hepatitis B Virus Inhibitors
Oya Unsal Tan, Jan Moncol, David Durantel
ChemistrySelect.2022;[Epub] CrossRef Hepatitis B functional cure and immune response
Jia-Rui Zheng, Zi-Long Wang, Bo Feng
Frontiers in Immunology.2022;[Epub] CrossRef Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
Jae Lee, Tae Lim, Hye Lee, Seung Kim, Jun Park, Do Kim, Sang Ahn, Hyun Lee, Jung Lee, Ja Kim, In Min, Beom Kim
Diagnostics.2022; 13(1): 3. CrossRef Critical Updates on Chronic Hepatitis B Virus Infection in 2021
Cyriac A Philips, Rizwan Ahamed, Jinsha K Abduljaleel, Sasidharan Rajesh, Philip Augustine
Cureus.2021;[Epub] CrossRef
|